Soon, New Therapies to Treat Hepatitis C

A novel method to block hepatitis C virus lifecycle has been discovered by scientists.

More than 170 million people worldwide suffer from hepatitis C, the disease caused by chronic HCV infection. The disease affects the liver and is one of the leading causes of liver cancer and liver transplant around the world.

Hepatitis C - Causes, Symptoms, Diagnosis, Treatment, Complications, Prevention
Hepatitis C is a contagious viral disease affecting the liver that is caused by the hepatitis C virus.

HCV is spread by blood-to-blood contact and there is no vaccine to prevent it. Current treatments for the disease are only moderately effective and can cause serious side effects.

"As HCV infects a person, it needs fat droplets in the liver to form new virus particles," said Francois Jean, Associate Professor in the Department of Microbiology and Immunology and Scientific Director of the Facility for Infectious Disease and Epidemic Research (FINDER) at UBC.

"In the process, it causes fat to accumulate in the liver and ultimately leads to chronic dysfunction of the organ."

Quiz on Liver
How many of us know that the liver is a vital organ the size of an American Football? To understand more about the liver and its functions spend a few minutes taking part in this quiz.

"HCV is constantly mutating, which makes it difficult to develop antiviral therapies that target the virus itself. So we decided to take a new approach."

Jean and his team developed an inhibitor that decreases the size of host fat droplets in liver cells and stops HCV from "taking residence," multiplying and infecting other cells.

Liver Cancer
Liver is the largest organ inside the human body. It performs 500 different functions and processes 720 liters of blood per day. The important functions of the liver, the development of liver cancer and it’s symptoms are presented in this interactive.

"Our approach would essentially block the lifecycle of the virus so that it cannot spread and cause further damage to the liver," said Jean.

According to Jean, HCV is one of a number of viruses that require fat to replicate in the human body. This new approach to curbing the replication of HCV could translate into similar therapies for other related re-emerging viruses that can cause serious and life threatening infections in humans, such as dengue virus.

Accuracy of Diagnosis in Hepatitis C Enhanced by New Fibrosis Classification
A report has revealed that a new classification for diagnosing fibrosis in patients with chronic hepatitis C virus (HCV) has shown to be as accurate as currently used algorithms

The study has been published in the journal PLoS Pathogens.

Source-ANI